Education
About Us
Working with TipRanks
Follow Us
Nuwellis (NUWE)
NASDAQ:NUWE
Earnings Data
Report Date
May 13, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.45Last Year’s EPS
-21Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 11, 2025
|% Change Since: -20.63%
|Next Earnings Date:May 13, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a balanced view with significant achievements such as the increase in consumables utilization, growth in the Critical Care business, and a major improvement in outpatient reimbursement. However, these were counterbalanced by challenges like the overall revenue decline, particularly in the heart failure and pediatrics segments, and the impact of a voluntary recall. The strategic initiatives, including the recent publication of clinical data and cost reductions, indicate positive future prospects.Company Guidance
During the Nuwellis earnings conference call for Q4 and full year 2024, the company provided several key metrics and guidance for 2025. Nuwellis reported $2.3 million in revenue for Q4 2024, marking a 9% year-over-year decrease, although consumables utilization increased by 21%. Critical Care revenue grew by 35% year-over-year, despite heart failure and pediatrics seeing declines of 36% and 20%, respectively. Gross margin improved to 58.4% from 54.4% in the previous year, while operating expenses decreased by 25% to $3.7 million, contributing to a reduced operating loss of $2.4 million compared to the prior year's $3.6 million. The company highlighted a new CMS reimbursement increase for outpatient ultrafiltration therapy, effective January 1, 2025, which is expected to drive top-line growth. Additionally, a recent publication in JACC: Heart Failure indicated a 60% reduction in heart failure events for patients using the Aquadex therapy compared to traditional IV diuretics, underscoring the potential for broader adoption of their technology.Increase in Consumables Utilization
There was a 21% increase in consumables utilization, indicating higher usage and adoption of the Aquadex system by clinicians.
Critical Care Business Growth
The Critical Care business saw a 35% year-over-year quarterly revenue growth, driven by an increase in both console sales and consumables utilization.
Publication of Clinical Data
A recent peer-reviewed publication in JACC: Heart Failure demonstrated a 60% reduction in heart failure events at 30 days for patients treated with Aquadex therapy compared to traditional IV diuretics.
Improvement in Gross Margin
Gross margin improved to 58.4% in Q4 2024 from 54.4% in the prior year quarter, primarily driven by higher manufacturing volumes and lower fixed overhead costs.
Operating Loss Reduction
Operating loss in Q4 2024 was reduced to $2.4 million from $3.6 million in the prior year, showing a $1.2 million improvement.
Significant Increase in Outpatient Reimbursement
Effective January 1, 2025, the facility reimbursement fee for Aquadex increased nearly four times from $413 to $1,639 per day, opening a new market in outpatient services.
---
NUWE Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
NUWE Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 11, 2025 | $1.26 | $1.21 | -3.97% |
| Nov 11, 2024 | $1.81 | $2.05 | +13.26% |
| Aug 13, 2024 | $2.65 | $2.14 | -19.25% |
| May 07, 2024 | $5.98 | $9.22 | +54.18% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Nuwellis (NUWE) report earnings?
Nuwellis (NUWE) is schdueled to report earning on May 13, 2025, TBA Not Confirmed.
What is Nuwellis (NUWE) earnings time?
Nuwellis (NUWE) earnings time is at May 13, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is NUWE EPS forecast?
NUWE EPS forecast for the fiscal quarter 2025 (Q1) is -0.45.
---